138 related articles for article (PubMed ID: 8632893)
1. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his).
Gollahon LS; Shay JW
Oncogene; 1996 Feb; 12(4):715-25. PubMed ID: 8632893
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells.
Cao Y; Gao Q; Wazer DE; Band V
Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of p53 mutants on the growth of human bronchial epithelial cells.
Coursen JD; Bennett WP; Khan MA; Forrester K; Pietenpol JA; Harris CC
Mol Carcinog; 1997 Jul; 19(3):191-203. PubMed ID: 9254886
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of normal mammary epithelial cells by wild-type p53.
Merlo GR; Venesio T; Taverna D; Marte BM; Callahan R; Hynes NE
Oncogene; 1994 Feb; 9(2):443-53. PubMed ID: 8290256
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
[TBL] [Abstract][Full Text] [Related]
6. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
7. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
9. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Oncogene; 1997 Jan; 14(4):499-506. PubMed ID: 9053847
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis.
Maxwell SA; Capp D; Acosta SA
Biochem Biophys Res Commun; 1997 Dec; 241(3):642-5. PubMed ID: 9434761
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
[TBL] [Abstract][Full Text] [Related]
12. Association of extended in vitro proliferative potential with loss of p16INK4 expression.
Noble JR; Rogan EM; Neumann AA; Maclean K; Bryan TM; Reddel RR
Oncogene; 1996 Sep; 13(6):1259-68. PubMed ID: 8808700
[TBL] [Abstract][Full Text] [Related]
13. Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase.
Kim H; Farris J; Christman SA; Kong BW; Foster LK; O'Grady SM; Foster DN
Biochem J; 2002 Aug; 365(Pt 3):765-72. PubMed ID: 11978176
[TBL] [Abstract][Full Text] [Related]
14. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
15. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells.
Garbe J; Wong M; Wigington D; Yaswen P; Stampfer MR
Oncogene; 1999 Apr; 18(13):2169-80. PubMed ID: 10327063
[TBL] [Abstract][Full Text] [Related]
16. The human p53 gene mutated at position 249 per se is not sufficient to immortalize human liver cells.
Schleger C; Becker R; Oesch F; Steinberg P
Hepatology; 1999 Mar; 29(3):834-8. PubMed ID: 10051487
[TBL] [Abstract][Full Text] [Related]
17. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
18. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis.
Katayose D; Wersto R; Cowan KH; Seth P
Cell Growth Differ; 1995 Oct; 6(10):1207-12. PubMed ID: 8845297
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
Li H; Cao Y; Berndt MC; Funder JW; Liu JP
Oncogene; 1999 Nov; 18(48):6785-94. PubMed ID: 10597287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
